Contrast-Enhanced Ultrasound Techniques for Guiding and Assessing Response to Locoregional Treatments for Hepatocellular Carcinoma

Most hepatocellular carcinomas (HCC) are diagnosed in patients with cirrhosis and/or when tumor burden is too advanced for surgical treatment. In many of these cases the only suitable therapy is locoregional, percutaneous and/or intraarterial treatment. Moreover, the best way to guide and assess response to locoregional HCC treatment are two issues under discussion today. First-generation and subsequent second-generation microbubble contrast agents, together with contrast-enhanced ultrasound (US) imaging, have expanded the role of US techniques in HCC treatments. In this review our purpose is to illustrate the advantages, limits and potential of contrast-enhanced US application for locoregional HCC treatment.

[1]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[2]  Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma. , 2010, European journal of radiology.

[3]  Manabu Watanabe,et al.  Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast‐enhanced ultrasonography using Sonazoid: Comparison with dynamic computed tomography , 2010, Journal of clinical ultrasound : JCU.

[4]  Kurinchi Gurusamy,et al.  Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. , 2010, Journal of hepatology.

[5]  G. Salvaggio,et al.  Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT , 2010, Abdominal Imaging.

[6]  M. D’Onofrio,et al.  Contrast-enhanced ultrasonography (CEUS) immediately after percutaneous ablation of hepatocellular carcinoma , 2009, La radiologia medica.

[7]  H. Shirato,et al.  Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection , 2009, Japanese Journal of Radiology.

[8]  M. Yoshikawa,et al.  Ultrasound‐guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B‐mode ultrasonography , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[9]  Sukru Mehmet Erturk,et al.  Is Contrast-Enhanced US Alternative to Spiral CT in the Assessment of Treatment Outcome of Radiofrequency Ablation in Hepatocellular Carcinoma? , 2009, Ultraschall in der Medizin.

[10]  Jordi Rimola,et al.  Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma , 2009, Cancer.

[11]  O. Catalano,et al.  Hepatocellular carcinoma treated with chemoembolization: Assessment with contrast-enhanced doppler ultrasonography , 1999, CardioVascular and Interventional Radiology.

[12]  Kinuyo Hatanaka,et al.  Response Evaluation of Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas: The Usefulness of Sonazoid-Enhanced Harmonic Sonography , 2008, Oncology.

[13]  A. Burroughs,et al.  Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma , 2008, Expert review of gastroenterology & hepatology.

[14]  B. Daniele,et al.  Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma , 2008 .

[15]  M. Okada,et al.  Ablation Therapy Guided by Contrast‐Enhanced Sonography with Sonazoid for Hepatocellular Carcinoma Lesions Not Detected by Conventional Sonography , 2008, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[16]  Yutaka Matsuyama,et al.  Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[17]  Luigi Solbiati,et al.  Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? , 2007, Hepatology.

[18]  Kinuyo Hatanaka,et al.  Defect Reperfusion Imaging, a Newly Developed Novel Technology using Sonazoid in the Treatment of Hepatocellular Carcinoma , 2008 .

[19]  K. Tsuchiya,et al.  Carbon dioxide microbubbles-enhanced sonographically guided radiofrequency ablation: treatment of patients with local progression of hepatocellular carcinoma , 2008, Radiation Medicine.

[20]  Xiao-Ling Yu,et al.  Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. , 2007, Ultrasound in medicine & biology.

[21]  K. Okazaki,et al.  Clinicopathologic study of small hepatocellular carcinoma with microscopic satellite nodules to determine the extent of tumor ablation by local therapy. , 2007, International journal of oncology.

[22]  H. Fukuda,et al.  Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent. , 2007, Clinical radiology.

[23]  M. Kudo,et al.  Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. , 2007, AJR. American journal of roentgenology.

[24]  Y. Kono,et al.  Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. , 2007, Journal of vascular and interventional radiology : JVIR.

[25]  E. Cholongitas,et al.  Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies , 2007, CardioVascular and Interventional Radiology.

[26]  S. Kumano,et al.  Usefulness of contrast‐enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[27]  J. Bruix,et al.  Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? , 2006, European Radiology.

[28]  P. Burns,et al.  Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography. , 2006, AJR. American journal of roentgenology.

[29]  Hyun Cheol Kim,et al.  Assessment of the Therapeutic Response of Hepatocellular Carcinoma Treated With Transcatheter Arterial Chemoembolization , 2006, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[30]  M. Pompili,et al.  Contrast‐enhanced gray‐scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[31]  K. Arii,et al.  Contrast Harmonic Sonographically Guided Radio Frequency Ablation for Spontaneous Ruptured Hepatocellular Carcinoma , 2005, Journal of ultrasound in medicine.

[32]  Y. Nakatani,et al.  Evaluation Using Contrast‐Enhanced Harmonic Gray Scale Sonography After Radio Frequency Ablation of Small Hepatocellular Carcinoma , 2005, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[33]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[34]  Usefulness of contrast-enhanced ultrasonography with a new contrast mode, Agent Detection Imaging, in evaluating therapeutic response in hepatocellular carcinoma treated with radio-frequency ablation therapy. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[35]  Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. , 2004, AJR. American journal of roentgenology.

[36]  清水 雅文.  Usefulness of contrast-enhanced ultrasonography with a new contrast mode, agent detection imaging, in evaluating therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation therapy , 2004 .

[37]  T. Maeno,et al.  Usefulness of contrast-enhanced ultrasonography with dynamic flow imaging to evaluate therapeutic effects for hepatocellular carcinoma. , 2003, Hepato-gastroenterology.

[38]  F. Izzo,et al.  Local ablation procedures in primary liver tumors: Levovist US versus spiral CTto evaluate therapeutic results. , 2003, Anticancer research.

[39]  Young Han Kim,et al.  Early Assessment of the Therapeutic Response to Radio Frequency Ablation for Hepatocellular Carcinoma , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[40]  L. Solbiati,et al.  Guidance and control of percutaneous treatments with contrast-enhanced ultrasound , 2003, European Radiology.

[41]  Masatoshi Kudo,et al.  Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. , 2003, AJR. American journal of roentgenology.

[42]  K. Shirato,et al.  Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. , 2003, AJR. American journal of roentgenology.

[43]  J. Bruix,et al.  Contrast‐enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation , 2003, Journal of clinical ultrasound : JCU.

[44]  M. Kudo,et al.  Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. , 2003, AJR. American journal of roentgenology.

[45]  K. Shirato,et al.  Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma. , 2003, AJR. American journal of roentgenology.

[46]  D. Choi,et al.  Assessment of Therapeutic Response in Hepatocellular Carcinoma Treated With Percutaneous Radio Frequency Ablation , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[47]  Y. Yamashita,et al.  [Usefulness of enhanced ultrasonography after administration of intravenous contrast agent in the evaluation of therapeutic effect in treatment of hepatocellular carcinoma, and efficacy of percutaneous ethanol injection therapy (PEIT) for residual tumor]. , 2001, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[48]  M. Kudo,et al.  Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. , 2001, Radiology.

[49]  Nonresectable Hepatocellular Carcinoma , 2001 .

[50]  C. Bartolozzi,et al.  Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome. , 2001, AJR. American journal of roentgenology.

[51]  L Pagliaro,et al.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.

[52]  S. Goldberg,et al.  Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. , 2001, AJR. American journal of roentgenology.

[53]  M. Pompili,et al.  Comparison between color power doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures , 2001, American Journal of Gastroenterology.

[54]  H. Sekihara,et al.  Using contrast-enhanced sonography to assess the effectiveness of transcatheter arterial embolization for hepatocellular carcinoma. , 2001, AJR. American journal of roentgenology.

[55]  M. Kudo,et al.  Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. , 2001, AJR. American journal of roentgenology.

[56]  H. Kirikoshi,et al.  Nonresectable hepatocellular carcinoma: improved percutaneous ethanol injection therapy guided by CO(2)-enhanced sonography. , 2001, AJR. American journal of roentgenology.

[57]  H K Lim,et al.  Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. , 2000, Radiology.

[58]  F. Izzo,et al.  Levovist-enhanced Doppler Sonography Versus Spiral Computed Tomography to Evaluate Response to Percutaneous Ethanol Injection in Hepatocellular Carcinoma , 2000, Journal of clinical gastroenterology.

[59]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[60]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[61]  C. Bartolozzi,et al.  Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: evaluation with contrast-enhanced harmonic power Doppler ultrasound , 2000, European Radiology.

[62]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[63]  A Paolicchi,et al.  Hepatocellular carcinoma treatment with percutaneous ethanol injection: evaluation with contrast-enhanced color Doppler US. , 1998, Radiology.

[64]  O. Catalano,et al.  [The correlation between Doppler echography with a contrast medium and CT in the study of a hepatocarcinoma submitted to chemoembolization]. , 1998, La Radiologia medica.

[65]  M. Ujita,et al.  [Usefulness of CO2 US angiography in treating hepatocellular carcinoma]. , 1998, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[66]  S. Sakaguchi,et al.  [Transcatheter arterial embolization of hepatocellular carcinoma using CO2-US]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[67]  S. Nakano,et al.  [The usefulness of percutaneous ethanol injection therapy under guidance with carbon dioxide contrast enhanced ultrasound sonography]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[68]  H. Tu,et al.  Intra‐arterial carbon dioxide‐enhanced ultrasonogram of hepatocellular carcinoma treated by transcatheter arterial embolization and percutaneous ethanol injection therapy , 1998, Journal of gastroenterology and hepatology.

[69]  J. Watarai,et al.  Use of carbon dioxide microbubble-enhanced sonographic angiography for transcatheter arterial chemoembolization of hepatocellular carcinoma. , 1997, AJR. American journal of roentgenology.

[70]  Y. Liaw,et al.  Non‐surgical treatment of hepatocellular carcinoma , 1997, Journal of gastroenterology and hepatology.

[71]  R Fiocca,et al.  Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. , 1997, Radiology.

[72]  M. Satoh,et al.  Hepatocellular carcinoma not detected with plain US: treatment with percutaneous ethanol injection under guidance with enhanced US. , 1992, Radiology.

[73]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[74]  M. Kudo,et al.  Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles. , 1992, Radiology.

[75]  O. Matsui.  [Imaging diagnosis of ruptured site in hepatocellular carcinoma]. , 1989, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[76]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[77]  S. Maki,et al.  Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium , 1985, Cancer.

[78]  J. Ludbrook,et al.  Spontaneous Rupture of Hepatocellular Carcinoma , 1972, British medical journal.